Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
ACS Appl Mater Interfaces ; 7(24): 13422-30, 2015 Jun 24.
Artículo en Inglés | MEDLINE | ID: mdl-26030661

RESUMEN

It has been newly discovered that by simply altering the applied voltage, the resultant electrospun prolamin protein fabrics can rapidly (within 30 s) form either flat sheets or self-rolled tubes when immersed in water. This phenomenon opens up many potential biomedical applications for drug delivery. The morphology and structure of both dry and wet fibers were characterized in detail. The hordein/zein fibers fabricated at relatively lower voltage were stabilized by the preaggregated nanoscale hydrophobic domains and exhibited restricted swelling while maintaining a flat sheet shape with minimal changes to secondary structure when immersed in water. By applying a higher voltage, we triggered a greater bending instability during the electrospinning process, and the hordein/zein network structure generated could rapidly relax in an aqueous environment. This increased mobility of molecular chains allowed the uneven aggregation of hydrophobic dopants, which catalyzed the self-rolling of the aligned fibers. Sessile drop measurements even showed a reduction in the contact angle from 106 to 39° for the fibers with 50% zein prepared at raised voltage, indicating the conversion of surface properties caused by the relaxation. All the fibers demonstrated low toxicity in human primary dermal fibroblast cell culture. Moreover, the electrospun fabrics exhibited a strong resistance to protein adsorption and cell attachment, and the release experiment indicated that both three-dimensional porous structures could serve as a carrier for controlled release of incorporated bioactive compounds into phosphate-buffered saline. Therefore, these electrospun prolamin protein fabrics represent an ideal and novel platform to develop nonadherent drug delivery systems for wound dressing and other biomedical applications.


Asunto(s)
Portadores de Fármacos/química , Técnicas Electroquímicas/métodos , Nanofibras/química , Prolaminas/química , Adhesión Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Células Cultivadas , Portadores de Fármacos/toxicidad , Fibroblastos , Humanos , Nanofibras/toxicidad , Prolaminas/toxicidad , Propiedades de Superficie
2.
Nutrients ; 4(4): 243-57, 2012 04.
Artículo en Inglés | MEDLINE | ID: mdl-22606367

RESUMEN

Celiac disease (CD), a common heritable chronic inflammatory condition of the small intestine caused by permanent intolerance to gluten/gliadin (prolamin), is characterized by a complex interplay between genetic and environmental factors. Developments in proteomics have provided an important contribution to the understanding of the biochemical and immunological aspects of the disease and the mechanisms involved in toxicity of prolamins. It has been demonstrated that some gliadin peptides resistant to complete proteolytic digestion may directly affect intestinal cell structure and functions by modulating gene expression and oxidative stress. In recent years, the creation of the two research fields Nutrigenomics and Nutrigenetics, has enabled the elucidation of some interactions between diet, nutrients and genes. Various dietary components including long chain ω-3 fatty acids, plant flavonoids, and carotenoids have been demonstrated to modulate oxidative stress, gene expression and production of inflammatory mediators. Therefore their adoption could preserve intestinal barrier integrity, play a protective role against toxicity of gliadin peptides and have a role in nutritional therapy of celiac disease.


Asunto(s)
Carotenoides/metabolismo , Enfermedad Celíaca/inmunología , Ácidos Grasos Omega-3/metabolismo , Polifenoles/metabolismo , Prolaminas/toxicidad , Carotenoides/uso terapéutico , Enfermedad Celíaca/dietoterapia , Ácidos Grasos Omega-3/uso terapéutico , Expresión Génica/inmunología , Humanos , Estrés Oxidativo/inmunología , Polifenoles/uso terapéutico
3.
Dig Liver Dis ; 43(1): 34-9, 2011 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-20554485

RESUMEN

BACKGROUND: Natural or induced variations in the noxiousness of gluten proteins for celiac disease (CD) patients are currently being investigated for their potential in breeding wheat crops with reduced toxicity. AIMS: We evaluated the bread wheat line C173 for its effects on the in vitro-grown duodenal mucosa of CD patients. METHODS: In vitro-grown duodenal mucosa biopsies of 19 CD patients on a gluten-free diet were exposed to peptic/tryptic-digested prolamins from bread wheat line C173 lacking gliadin-glutenin subunits, analyzed for morphology, cytokine and anti-tTG antibody production, and compared with mucosa biopsies exposed to prolamins from wild-type cv. San Pastore. RESULTS: Duodenal mucosa biopsies exposed to prolamins from C173 and San Pastore released higher amounts of IFN-γ, IL-2, IL-10 and anti-tTG antibodies in the culture medium than untreated controls. The line C173 differed from cv. San Pastore as it did not produce negative effects on enterocyte height, suggesting that manipulating prolamin composition can affect innate immune responses of CD mucosa to wheat gluten. CONCLUSIONS: Our data demonstrated that this gliadin-deficient wheat has a lower direct toxicity but activates an immunologic reaction of the duodenal mucosa like that of the common wheat species.


Asunto(s)
Enfermedad Celíaca/metabolismo , Mucosa Intestinal/metabolismo , Prolaminas/toxicidad , Triticum/toxicidad , Anticuerpos/metabolismo , Enfermedad Celíaca/inmunología , Enfermedad Celíaca/patología , Eliminación de Gen , Humanos , Interferón gamma/metabolismo , Interleucina-10/metabolismo , Interleucina-2/metabolismo , Mucosa Intestinal/inmunología , Mucosa Intestinal/patología , Prolaminas/inmunología , Técnicas de Cultivo de Tejidos , Triticum/genética , Triticum/inmunología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA